Welcure Drugs and Pharmaceuticals Limited (BOM:524661)

BOM:524661 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	433	1,023	51	54	132	25
Market Cap Growth	156.11%	1913.04%	-6.47%	-58.85%	419.68%	370.01%
Enterprise Value	1,663	1,020	50	40	132	25
Last Close Price	0.35	0.83	0.34	0.37	0.89	0.17
PE Ratio	0.91	47.13	-	53.41	559.87	46.06
PS Ratio	0.12	4.17	-	-	125.73	19.05
PB Ratio	0.32	1.00	3.79	3.59	141.95	36.59
P/TBV Ratio	0.32	1.00	3.79	3.59	141.95	36.59
P/FCF Ratio	-	-	-	50.81	711.56	60.22
P/OCF Ratio	-	-	-	50.81	711.56	60.22
EV/Sales Ratio	0.46	4.16	-	-	125.64	18.94
EV/EBITDA Ratio	3.80	36.61	41.29	89.54	-	-
EV/EBIT Ratio	3.80	36.71	58.48	96.55	559.47	45.90
EV/FCF Ratio	-	-	-	37.12	711.06	59.86
Debt / Equity Ratio	0.92	1.20	-	-	-	-
Debt / EBITDA Ratio	2.81	44.19	-	-	-	-
Asset Turnover	0.81	0.18	-	-	1.24	2.73
Quick Ratio	1.02	0.46	0.71	0.09	17.30	13.21
Current Ratio	1.46	4.41	1.04	0.43	17.30	13.21
Return on Equity (ROE)	27.51%	4.18%	-12.24%	12.65%	29.03%	131.74%
Return on Assets (ROA)	6.06%	1.29%	3.72%	3.16%	17.36%	70.45%
Return on Invested Capital (ROIC)	13.45%	1.24%	6.09%	5.33%	96.32%	355.34%
Return on Capital Employed (ROCE)	17.00%	1.20%	6.40%	2.70%	25.40%	79.20%
Earnings Yield	75.09%	2.12%	-3.44%	1.87%	0.18%	2.17%
FCF Yield	-	-217.11%	-2.51%	1.97%	0.14%	1.66%
Buyback Yield / Dilution	-22.17%	-477.75%	-0.54%	-10.90%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.